JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2013, 62(6):259-263

Monitoring of formation of diclofenac sodium salt hydrates and their influence on the drug dissolution from prepared tablets

Petr Doležel1, Jan Muselík1,*, Michaela Králová2, David Vetchý1
1 Ústav technologie léků, Veterinární a farmaceutická univerzita, Brno
2 Ústav hygieny a technologie mléka, Fakulta veterinární hygieny a ekologie, Veterinární a farmaceutická univerzita Brno

NIR spectroscopy together with multivariate data analysis were used to analyze the hydrates of diclofenac sodium prepared from the non-aqueous solvents tetrahydrofuran and methanol under standard laboratory conditions at 20 °C and relative humidity less than 60%. It was confirmed that the developed PLS regression model can monitor the process of formation of hydrates. It was also found that the hydrated form of diclofenac sodium arises during the preparation of the dosage form the using technology of impregnating the solid carrier by non-aqueous solvents, which resulted in reducing of the drug release rate from prepared tablets up to twice. NIR spectroscopy was confirmed as one of the effective PAT (Process Analytical Technology) methods.

Keywords: process analytical technology method; PLS regression; NIR spectroscopy; hydrates; impregnation; diclofenac sodium

Received: September 16, 2013; Accepted: November 11, 2013; Published: June 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Doležel P, Muselík J, Králová M, Vetchý D. Monitoring of formation of diclofenac sodium salt hydrates and their influence on the drug dissolution from prepared tablets. Čes. slov. farm. 2013;62(6):259-263.
Download citation

References

  1. Bartolomei M., Rodomonte A., Antoniella E., Minelli G., Bertocchi P. Hydrate modifications of the non-steroidal anti-inflammatory drug diclofenac sodium: Solid-state characterisation of a trihydrate form. J Pharmaceut Biomed 2007; 45, 443-449. Go to original source... Go to PubMed...
  2. Kou X., Chan L. W., Steckel H., Heng P. W. S. Physico-chemical aspects of lactose for inhalation. Adv Drug Deliver Rev 2012; 64, 220-232. Go to original source... Go to PubMed...
  3. Karner S., Urbanetz N. A. The impact of electrostatic charge in pharmaceutical powders with specific focus on inhalation-powders. J Aerosol Sci 2011; 42, 428-445. Go to original source...
  4. Bartolomei M., Bertocchi P., Antoniella E., Rodomonte A. Physico-chemical characterisation and intrinsic dissolution studies of a new hydrate form of diclofenac sodium: comparison with anhydrous form. J Pharmaceut Biomed 2006; 40, 1105-1113. Go to original source... Go to PubMed...
  5. Muselík J. Aplikace blízké infračervené spektroskopie ve farmaceutické analýze. Chem Listy 2012; 106, 10-15.
  6. Esbensen K. H. Multivariate Data Analysis - In Praktice, 5. vyd. CAMO Process AS 2004; 598.
  7. Franc A., Rabišková M., Goněc R. Impregnation: a progressive method in the production of solid dosage forms with low content of poorly soluble drugs. Eur J Parent Pharm Sci 2011; 16, 85-93.
  8. Franc A., Rabišková M., Goněc R. Impregnation method in the production of solid dosage forms containing low-dose poorly absorbable drugs. Ind Pharm 2011; 26, 7-9.
  9. Llina's A., Burley J. C., Box K. J., Glen R. C., Goodman J. M. Diclofenac Solubility: Independent determination of the intrinsic solubility of three crystal forms. J Med Chem 2007; 50, 979-983. Go to original source... Go to PubMed...
  10. Gastaldi D., Canonico F., Irico S., Pellerej D., Paganini M. C. Near-infrared spectroscopy investigation on the hydration degree of a cement paste. J Mater Sci 2010; 45, 3169-3174. Go to original source...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.